These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11600356)

  • 41. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463.
    Imbertson LM; Beaurline JM; Couture AM; Gibson SJ; Smith RM; Miller RL; Reiter MJ; Wagner TL; Tomai MA
    J Invest Dermatol; 1998 May; 110(5):734-9. PubMed ID: 9579537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional complementation of the yeast divalent cation transporter family SMF by NRAMP2, a member of the mammalian natural resistance-associated macrophage protein family.
    Pinner E; Gruenheid S; Raymond M; Gros P
    J Biol Chem; 1997 Nov; 272(46):28933-8. PubMed ID: 9360964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nramp1 locus encodes a 65 kDa interferon-gamma-inducible protein in murine macrophages.
    Atkinson PG; Blackwell JM; Barton CH
    Biochem J; 1997 Aug; 325 ( Pt 3)(Pt 3):779-86. PubMed ID: 9271100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo.
    Govoni G; Gauthier S; Billia F; Iscove NN; Gros P
    J Leukoc Biol; 1997 Aug; 62(2):277-86. PubMed ID: 9261342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. I-A beta gene expression regulation in macrophages derived from mice susceptible or resistant to infection with M. bovis BCG.
    Barrera LF; Kramnik I; Skamene E; Radzioch D
    Mol Immunol; 1997 Mar; 34(4):343-55. PubMed ID: 9244347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo and In vitro interferon induction in chickens by S -28828, an imidazoquinolinamine immunoenhancer.
    Karaca K; Sharma JM; Tomai MA; Miller RL
    J Interferon Cytokine Res; 1996 Apr; 16(4):327-32. PubMed ID: 9162527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome.
    Gruenheid S; Pinner E; Desjardins M; Gros P
    J Exp Med; 1997 Feb; 185(4):717-30. PubMed ID: 9034150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation.
    Lang T; Prina E; Sibthorpe D; Blackwell JM
    Infect Immun; 1997 Feb; 65(2):380-6. PubMed ID: 9009286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains.
    Vidal SM; Pinner E; Lepage P; Gauthier S; Gros P
    J Immunol; 1996 Oct; 157(8):3559-68. PubMed ID: 8871656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunomodulating and antiviral activities of the imidazoquinoline S-28463.
    Tomai MA; Gibson SJ; Imbertson LM; Miller RL; Myhre PE; Reiter MJ; Wagner TL; Tamulinas CB; Beaurline JM; Gerster JF
    Antiviral Res; 1995 Nov; 28(3):253-64. PubMed ID: 8629817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
    Bernstein DI; Miller RL; Harrison CJ
    J Infect Dis; 1993 Mar; 167(3):731-5. PubMed ID: 8382722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro.
    Weeks CE; Gibson SJ
    J Interferon Res; 1994 Apr; 14(2):81-5. PubMed ID: 8077768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression.
    Kono T; Kondo S; Pastore S; Shivji GM; Tomai MA; McKenzie RC; Sauder DN
    Lymphokine Cytokine Res; 1994 Apr; 13(2):71-6. PubMed ID: 8061117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-gamma and infection with BCG.
    Barrera LF; Kramnik I; Skamene E; Radzioch D
    Immunology; 1994 Jul; 82(3):457-64. PubMed ID: 7959883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.
    Harrison CJ; Miller RL; Bernstein DI
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2059-64. PubMed ID: 7811019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Bcg gene story.
    Skamene E
    Immunobiology; 1994 Oct; 191(4-5):451-60. PubMed ID: 7713559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine induction by the immunomodulators imiquimod and S-27609.
    Testerman TL; Gerster JF; Imbertson LM; Reiter MJ; Miller RL; Gibson SJ; Wagner TL; Tomai MA
    J Leukoc Biol; 1995 Sep; 58(3):365-72. PubMed ID: 7665993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.